145 related articles for article (PubMed ID: 10609868)
1. Lipid soluble vitamins in gene regulation.
Carlberg C
Biofactors; 1999; 10(2-3):91-7. PubMed ID: 10609868
[TBL] [Abstract][Full Text] [Related]
2. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and molecular action of retinoids and vitamin D in skin.
Kang S; Li XY; Voorhees JJ
J Investig Dermatol Symp Proc; 1996 Apr; 1(1):15-21. PubMed ID: 9627686
[TBL] [Abstract][Full Text] [Related]
5. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
Kahlen JP; Carlberg C
Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
Jiménez-Lara AM; Aranda A
Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
[TBL] [Abstract][Full Text] [Related]
7. Competition for a unique response element mediates retinoic acid inhibition of vitamin D3-stimulated transcription.
Cao X; Teitelbaum SL; Zhu HJ; Zhang L; Feng X; Ross FP
J Biol Chem; 1996 Aug; 271(34):20650-4. PubMed ID: 8702813
[TBL] [Abstract][Full Text] [Related]
8. 1 alpha,25-dihydroxyvitamin D3 receptor as a mediator of transrepression of retinoid signaling.
Polly P; Carlberg C; Eisman JA; Morrison NA
J Cell Biochem; 1997 Dec; 67(3):287-96. PubMed ID: 9361184
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D-retinoid association: molecular basis and clinical applications.
Carlberg C; Saurat JH
J Investig Dermatol Symp Proc; 1996 Apr; 1(1):82-6. PubMed ID: 9627699
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of TauT by calcitriol and retinoic acid via VDR/RXR in LLC-PK1 and MCF-7 cells.
Chesney RW; Han X
Adv Exp Med Biol; 2013; 776():291-305. PubMed ID: 23392891
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
13. Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues.
Carlberg C; Quack M; Herdick M; Bury Y; Polly P; Toell A
Steroids; 2001; 66(3-5):213-21. PubMed ID: 11179728
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the chimeric retinoic acid receptor RARalpha/VDR.
Pemrick SM; Abarzúa P; Kratzeisen C; Marks MS; Medin JA; Ozato K; Grippo JF
Leukemia; 1998 Apr; 12(4):554-62. PubMed ID: 9557614
[TBL] [Abstract][Full Text] [Related]
16. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
17. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors.
Carlberg C; Mathiasen IS; Saurat JH; Binderup L
J Steroid Biochem Mol Biol; 1994 Nov; 51(3-4):137-42. PubMed ID: 7981122
[TBL] [Abstract][Full Text] [Related]
18. Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors.
Schräder M; Müller KM; Becker-André M; Carlberg C
J Mol Endocrinol; 1994 Jun; 12(3):327-39. PubMed ID: 7916971
[TBL] [Abstract][Full Text] [Related]
19. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
20. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
Kersten S; Dawson MI; Lewis BA; Noy N
Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
